Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample |
| |
Authors: | Ioannis Michopoulos Athanasios Douzenis Christina Kalkavoura Christos Christodoulou Panayiota Michalopoulou Georgia Kalemi Katerina Fineti Paulos Patapis Konstantinos Protopapas Lefteris Lykouras |
| |
Institution: | 1. Department of Neurology, Eginitio Hospital, University of Athens, Greece 2. Department of Neurology III, Aristotle University of Thessaloniki, Greece 3. Department of Psychiatry III, Aristotle University of Thessaloniki, Greece
|
| |
Abstract: | Background The aim of the study was to assess the plasma levels of homocysteine in patients with multiple sclerosis (MS) and to investigate whether an association with depression exists. Methods Plasma homocysteine (Hcy), vitamin B12 and plasma folate were measured in 65 moderately disabled patients with relapsing/remitting MS (RR-MS) and 60 healthy controls. All subjects were assessed with the Beck Depression Inventory (BDI). Results Hcy levels were significantly increased in MS patients compared to controls (13.5 ± 4.7 μmol/l vs 8.5 ± 3.1, p < 0.001). A significant correlation was found between Hcy levels and BDI scores (Pearson r = 0.3025, p < 0.05). Plasma Hcy was not related to Extended Disability Status Scale (EDSS) score, age, disease duration or vitamin B12 and folate. Conclusion Moderately disabled MS patients with elevated Hcy levels are particularly prone to develop depressive symptomatology. Further study is warranted in order to elucidate the prognostic and therapeutic implications of this novel finding. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|